Advancing Patient Care
Clinical trials are essential for developing new treatments. Our patients have the opportunity to participate in Phase II and Phase III trials, giving them access to novel drugs and immunotherapies before they are widely available on the market, all under rigorous ethical oversight.
Research Activities
- Conducting Phase II and Phase III global and national oncology trials.
- Investigator-initiated studies focusing on highly prevalent local cancers (e.g., Gallbladder and Oral cavity cancers).
- Real-world evidence research to evaluate long-term drug efficacy.
- Patient-reported outcome studies focused on measuring quality of life.